FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
Panel to Discuss Titan NDA for Opioid Dependence
02/27/2013
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
FDA AI Inspections Prompts Industry Readiness Strategy Rethink
Agency Defends Generic Drug Oversight
PhRMA Urges FDA to Clarify Digital Health Technology Standards
FDA Seeks Industry Data for Kidney Biomarker Initiative
Alert on GE HealthCare Infant Resuscitation Systems
FDA Expands Pfizer Bleeding Drug Approval
Guidance Details Post-Approval Responsibilities for Generics
Stakeholders Press FDA to Pause Voucher Program Amid Transparency Concerns
LATEST NEWS
Read More
FDA General
FDA AI Inspections Prompts Industry Readiness Strategy Rethink
Read More
Human Drugs
Agency Defends Generic Drug Oversight
Read More
FDA General
PhRMA Urges FDA to Clarify Digital Health Technology Standards
Read More
Human Drugs
FDA Seeks Industry Data for Kidney Biomarker Initiative
FDA Webview Free Daily e-Newsletter
Free Sign-Up
